SAN DIEGO, June 9 /PRNewswire/ -- Synteract, Inc. announces successful upgrade and full validation of Oracle AERS(R), version 4.3. Using AERS, Synteract continues to perform safety surveillance, reporting and management, and is a value-added service provider of the product. The upgraded version has enhanced medical information and product complaint features. The Company's Safety Department specializes in the performance of pharmacovigilance services, such as case entry, safety monitoring and assessment, regulatory submission and reporting, and safety database management. Synteract also offers secured access to AERS as an Application Service Provider (ASP). This allows clients the ability to enter, track and report their safety data from any location, while Synteract provides the technical support and maintenance of the system. Oracle AERS is a full-featured adverse event reporting system, designed to meet safety data processing needs for regulatory submission and marketing surveillance and reporting by pharmaceutical, biotechnology, and biomedical firms. As a single repository of data, the system features custom query for data browsing and audit trail to track all changes to information. Synteract has been using AERS (formerly known as EventNet) for three years. "Synteract's growing utilization and expertise with AERS allows us to better serve our clients, not only by helping to meet their product safety reporting needs, as required under law, but also by assisting with an ever expanding focus to proactively identify product safety issues through ongoing trend monitoring and analysis", stated Stewart Bieler, Vice President of Clinical Operations at Synteract. About Synteract Inc. Established in 1995, Synteract is a privately held, full-service contract research organization, dedicated to meeting the various needs of biotechnology, biomedical, pharmaceutical, and drug industry firms. Based in Carlsbad, CA, with a branch office in Pennsylvania, the Company provides expertise in a wide range of therapeutic areas and maintains a wealth of knowledge in oncology, ophthalmology, HIV, sexual dysfunction, cardiovascular disease, and pain. Since 2000, it has been a key development shop for web, wireless and voice data solutions that speed the completion of clinical trials and assist in access to clinical trials information. This includes technologies such as electronic data capture (EDC), interactive voice response systems (IVRS), and automated safety tracking and reporting. Synteract has offices in Carlsbad, CA and Philadelphia, PA. For information please visit us at or call (760) 268.8200. http://www.synteract.com/ CONTACT: Stewart Bieler, +1-760-268-8200 firstname.lastname@example.org
SOURCE Synteract, Inc.